Take Solutions Ltd

Take Solutions Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Take Solutions Ltd

₹ 29.6 1.47%
25 May - close price
takesolutions.com BSE: 532890 NSE: TAKE
About

Incorporated in 2000, TAKE Solutions Ltd is in the business of Life Sciences and Support Services[1]

Key Points

Business Overview:[1]
Singapore-based TAKE Solutions Pte Limited holds a 52.90% stake in TSL, serving as the holding company. TSL specializes in Life Sciences and Supply Chain Management, providing comprehensive services in clinical development and specific offerings in supply chain. The company is involved in clinical trials, generics support, including bio-availability & bioequivalent studies, regulatory filing, and pharmacovigilance.

Website BSE NSE - BE
  • Market Cap ₹ 438 Cr.
  • Current Price ₹ 29.6
  • High / Low ₹ 50.1 / 8.16
  • Stock P/E 162
  • Book Value ₹ 1.93
  • Dividend Yield 0.00 %
  • ROCE 11.6 %
  • ROE 9.99 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 15.4 times its book value
  • Tax rate seems low
  • Company has a low return on equity of -46.6% over last 3 years.
  • Earnings include an other income of Rs.6.63 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Research, Analytics & Technology

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
14.79 5.42 0.00 0.00 0.00 0.90 0.00 0.00 0.00 0.00 -0.04 0.00 0.00
12.08 4.41 1.08 1.51 7.94 0.61 0.90 0.76 0.70 2.02 0.28 0.35 0.79
Operating Profit 2.71 1.01 -1.08 -1.51 -7.94 0.29 -0.90 -0.76 -0.70 -2.02 -0.32 -0.35 -0.79
OPM % 18.32% 18.63% 32.22%
2.05 -0.34 0.13 0.71 -192.77 -47.94 -26.56 1.93 5.69 0.01 0.01 1.46 5.18
Interest 0.47 0.21 0.19 0.17 0.17 0.16 0.16 0.22 0.20 0.15 0.15 0.00 0.00
Depreciation 0.28 0.30 0.30 0.11 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Profit before tax 4.01 0.16 -1.44 -1.08 -200.89 -47.82 -27.63 0.94 4.78 -2.16 -0.46 1.11 4.39
Tax % -2.74% 112.50% -24.31% 331.48% 0.30% 0.13% -0.22% 0.00% 0.00% 0.00% 34.78% 0.00% 0.00%
4.12 -0.02 -1.10 -4.65 -201.49 -47.88 -27.57 0.94 4.78 -2.17 -0.62 1.11 4.39
EPS in Rs 0.28 -0.00 -0.07 -0.31 -13.62 -3.24 -1.86 0.06 0.32 -0.15 -0.04 0.08 0.30
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
25.89 23.57 18.84 2.44 21.96 2.47 10.72 18.00 56.23 5.42 0.90 0.00
24.45 18.36 22.44 18.64 35.83 19.38 17.59 31.35 53.37 14.94 2.95 3.45
Operating Profit 1.44 5.21 -3.60 -16.20 -13.87 -16.91 -6.87 -13.35 2.86 -9.52 -2.05 -3.45
OPM % 5.56% 22.10% -19.11% -663.93% -63.16% -684.62% -64.09% -74.17% 5.09% -175.65% -227.78%
12.80 15.64 22.05 32.81 34.35 26.08 15.32 -459.92 3.63 -192.27 -66.89 6.63
Interest 0.11 0.40 3.08 1.07 0.17 0.49 0.36 0.30 0.68 0.74 0.75 0.29
Depreciation 0.74 0.19 0.80 0.80 0.80 1.74 1.57 1.23 1.11 0.72 0.05 0.01
Profit before tax 13.39 20.26 14.57 14.74 19.51 6.94 6.52 -474.80 4.70 -203.25 -69.74 2.88
Tax % 15.46% 10.02% 1.10% -3.39% 10.81% -11.38% -19.63% 0.50% 8.72% 1.97% 0.00% 5.56%
11.32 18.23 14.42 15.25 17.40 7.74 7.79 -477.17 4.29 -207.25 -69.74 2.72
EPS in Rs 0.92 1.49 1.08 1.03 1.18 0.52 0.53 -32.26 0.29 -14.01 -4.71 0.18
Dividend Payout % 106.01% 65.88% 92.37% 155.17% 85.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -100%
Compounded Profit Growth
10 Years: -15%
5 Years: 20%
3 Years: -32%
TTM: -73%
Stock Price CAGR
10 Years: -16%
5 Years: -15%
3 Years: 19%
1 Year: 208%
Return on Equity
10 Years: -12%
5 Years: -53%
3 Years: -47%
Last Year: 10%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 12.00 12.01 13.32 14.79 14.79 14.79 14.79 14.79 14.79 14.79 14.79 14.79
Reserves 304.24 306.70 504.69 754.74 747.66 751.03 760.28 283.65 287.98 80.62 10.97 13.69
0.00 72.77 0.00 0.00 0.00 3.85 0.00 2.39 1.82 0.00 0.00 0.00
8.80 22.35 16.03 7.15 11.81 6.62 11.20 10.94 14.11 23.77 5.91 1.57
Total Liabilities 325.04 413.83 534.04 776.68 774.26 776.29 786.27 311.77 318.70 119.18 31.67 30.05
0.63 0.48 4.60 3.86 3.07 5.97 4.43 3.24 2.12 0.11 0.01 0.00
CWIP 0.00 2.16 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 234.38 330.39 359.92 413.87 511.72 517.32 516.78 154.68 242.56 101.87 0.00 0.25
90.03 80.80 169.52 358.95 259.47 253.00 265.06 153.85 74.02 17.20 31.66 29.80
Total Assets 325.04 413.83 534.04 776.68 774.26 776.29 786.27 311.77 318.70 119.18 31.67 30.05

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-2.55 -10.77 -32.96 -24.02 12.91 -14.91 -2.66 32.58 26.89 -4.48 -19.51 -0.62
55.39 -91.88 -23.57 -87.92 -111.90 21.79 13.42 -40.19 -22.37 -1.02 22.21 -2.00
-11.96 60.53 57.88 239.40 -28.45 -8.26 -0.25 -1.11 -0.84 -0.23 -0.04 -0.29
Net Cash Flow 40.87 -42.12 1.36 127.46 -127.44 -1.38 10.51 -8.72 3.69 -5.73 2.66 -2.91
Free Cash Flow -2.36 -12.96 -36.01 -24.08 12.90 -14.91 -2.69 32.54 26.89 -4.49 -19.51 -0.62
CFO/OP -12% -159% 785% 129% -101% 81% 37% -245% 1,095% 40% 966% 13%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 42.58 57.76 61.61 136.13 106.87 1,034.41 80.69 87.19 0.00 0.00 0.00
Inventory Days
Days Payable
Cash Conversion Cycle 42.58 57.76 61.61 136.13 106.87 1,034.41 80.69 87.19 0.00 0.00 0.00
Working Capital Days 394.32 -731.70 1,958.48 26,942.68 3,456.03 33,992.29 7,838.99 1,844.47 241.86 -1,163.02 5,406.06
ROCE % 4.24% 4.40% 3.95% 2.44% 2.46% 0.97% -0.90% 0.50% 3.57% -4.68% 17.96% 11.65%

Insights

In beta
Mar 2014 Mar 2015 Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Jun 2023
New Client Logos Added
Number

Log in to view insights

Please log in to see hidden values.

Login
Total Headcount (Group)
Number
Order Book
USD Million
Days Sales Outstanding (DSO) / Receivables Cycle
Days
Revenue Contribution - Life Sciences Vertical
%
Clinical Trial Bed Capacity (Ecron Acunova)
Number

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

1 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
53.41% 53.41% 53.41% 53.41% 53.41% 53.41% 53.41% 53.41% 53.34% 5.19% 0.00% 0.00%
0.13% 0.00% 0.00% 0.02% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.56% 0.28%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.00% 0.00% 0.00% 0.00%
46.46% 46.57% 46.59% 46.56% 46.58% 46.58% 46.59% 46.58% 46.65% 94.81% 99.44% 99.73%
No. of Shareholders 82,04581,18379,33681,93880,28878,03377,16375,98875,14174,41070,32464,699

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls